Public Statement 1/18/24
On January 17, Equitas Health sent public comments on changes to Rule 5122-14-12 & the addition of Rule 5122-26-19 proposed by Gov. DeWine & the Ohio Department of Mental Health and Addiction Services (MHAS). If approved, both rules would greatly reduce access to lifesaving gender-affirming in Ohio. Equitas Health strongly recommends that MHAS makes none of the proposed changes to Rule 5122-14-12 & rejects Rule 5122-26-19 completely.
Tomorrow is the last day to send public comments to MHAS on their proposed restrictions to gender-affirming care. Tell MHAS how you feel about their attempt to deny lifesaving healthcare to trans people in Ohio. Send an email to MH-SOT-rules@mha.ohio.gov by 5 PM on Jan. 19.
Please use “Comments on Gender Transition Care Rules” as the subject line of your email.
For ongoing updates, community resources, and ways you can help fight to protect gender-affirming care in Ohio, visit protectgac.equitashealth.com.
Read our full comments on both rules here.
Public Statement 9/21/24
Our focus remains on integrating our programs to better serve historically neglected communities, always with an understanding of the unique and intersectional needs of the diverse LGBTQ+ population.
Public Statement 8/26/24
Johnson & Johnson, one of the world’s largest drugmakers, announced last Friday that it will discontinue upfront 340B pricing on two medications for disproportionate share hospital (DSH) covered entities. The move is part of a sustained campaign by large drug manufacturers to undermine the federal 340B Drug Pricing Program for participating hospitals and covered entities such as Equitas Health.
Public Statement 8/14/24
Blog 3/29/24
Equitas Health is pleased to announce that a collective bargaining agreement has been reached with Equitas Health Workers United Local #6609. Members of the bargaining unit voted this week, and the result was resounding support for ratification of the agreement.
Blog 2/26/24
Blog 6/2/23
Blog 11/21/24
Blog 11/7/24
Blog 10/16/24